AlphaYou
Overview
Smart money at a glance
Filings to Sep 28, 2026No insider open-market trades in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
- Company insidersSEC Form 4, last 90 days
- $0No open-market trades
- CongressSTOCK Act, last 180 days
- NoneNo trades disclosed
- Big fundsSEC 13F, quarter ended Jun 30, 2026
- 3 added, 1 cutMore adding
- Federal contractsUSAspending.gov, last 12 months
- No awardsNone on record
Key stats
Fundamentals Sep 27- Open
- $23.43
- 52-wk high
- $29.99
- High
- $23.71
- 52-wk low
- $15.72
- Low
- $23.20
- Prev close
- $23.48
- Mkt cap
- $12.08B
- Volume
- 6.57M
- Fwd P/E
- 11.6x
- Beta
- 0.59
- Div yield
- 0.85%
- P/S
- 1.1x
- P/B
- 2.0x
- Profit margin
- -9.3%
- Op margin
- +14.4%
- ROE
- -14.4%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsQuestions about BAX filings
Are insiders buying or selling Baxter International Inc (BAX) stock?
Neither. Baxter International Inc (BAX) insiders filed no open-market purchases or sales in the 90 days to Sep 28, 2026, according to SEC Form 4 filings.
Which members of Congress have traded BAX recently?
None. No member of Congress disclosed a BAX trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.
How current is this BAX smart-money data?
This summary uses filings available on Sep 28, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
Smart money
8 funds hold a position.
What funds are doing
Buys/Adds (2)
- AQ
AQR
$32.5M
added
- GA
Gotham Asset
$12.3M
added
Sells/Trims (1)
- MI
Millennium
$29.1M
trimmed
How top traders are positioned
No tracked top-trader positions in BAX right now.
Live Hyperliquid positioning - not every stock is covered
Earnings
Earnings came in 55.6% above what analysts expected.
Earnings per share
$0.36 expected
Reports Oct 29, 2026, in 31 days
Estimates as of Sep 27, 2026
EPS expected
$0.50 to $0.54
Revenue expected
11 analysts
Last 30 days
Analysts cutting estimates
Financials
What it sold, what it cost, what was left.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $2.83B | $2.97B | $2.70B | $2.96B |
| Cost of what it sold | $1.89B | $2.40B | $1.81B | $1.93B |
| Gross profit | $950.0M | $577.0M | $891.0M | $1.03B |
| What it spent | ||||
| Research and development | $118.0M | $126.0M | $139.0M | $129.0M |
| Sales and admin | $708.0M | $761.0M | $728.0M | $735.0M |
| Other operating costs | -$48.0M | $419.0M | -$42.0M | -$49.0M |
| Total operating expenses | $778.0M | $1.31B | $825.0M | $815.0M |
| What was left | ||||
| Operating profit | $172.0M | -$729.0M | $66.0M | $217.0M |
| Interest on debt | $68.0M | $69.0M | $78.0M | $77.0M |
| Profit before tax | $121.0M | -$756.0M | -$6.0M | $158.0M |
| Tax | $172.0M | $279.0M | $11.0M | $23.0M |
| Net profit | -$46.0M | -$1.13B | -$15.0M | $126.0M |
| EBITDA | $426.0M | -$447.0M | $297.0M | $474.0M |
Technicals
Price structure
This stock is under pressure, and looks oversold after a sharp drop.
Trend
Under pressure
25 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace